NEOGENOMICS INC NEO

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $17.44
Market Cap $2.27B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑10.1% YoY
$727.33M
3-Yr CAGR: 12.6%
Net Income ↓-37.2% YoY
-$108.03M
Net Margin: -14.9%
Free Cash Flow ↑36.0% YoY
-$21.78M
FCF Yield: -0.96%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-12.9%
ROA: -7.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (NEO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $244.1M $110.4M $-5.7M 0.00% $21.5M $13.9M
FY 2017 $258.6M +6.0% $120.3M $-0.8M +85.2% 0.00% $18.0M $4.3M -68.8%
FY 2018 $276.7M +7.0% $127.3M $2.6M +412.1% 0.00% $44.8M $30.5M +601.1%
FY 2019 $408.8M +47.7% $196.8M $8.0M +203.3% 0.00% $23.4M $3.3M -89.0%
FY 2020 $444.4M +8.7% $185.9M $4.2M -47.9% 0.00% $1.5M $-27.6M -927.4%
FY 2021 $484.3M +9.0% $187.1M $-8.3M -300.1% 0.00% $-26.7M $-90.9M -228.8%
FY 2022 $509.7M +5.2% $187.9M $-144.2M -1,628.2% 0.00% $-66.0M $-96.9M -6.6%
FY 2023 $591.6M +16.1% $244.6M $-88.0M +39.0% 0.00% $-2.0M $-30.7M +68.3%
FY 2024 $660.6M +11.6% $290.1M $-78.7M +10.5% 0.00% $7.0M $-34.0M -10.9%
FY 2025 $727.3M +10.1% $314.3M $-108.0M -37.2% 0.00% $5.2M $-21.8M +36.0%
$

Valuation

Market Price $17.44
Market Cap $2.27B
Enterprise Value $2.45B
P/E Ratio N/A
P/B Ratio 2.71
FCF Yield -0.96%
Dividend Yield N/A
Shares Outstanding 130,211,800
%

Profitability & Margins

Gross Margin 43.21%
Operating Margin -15.93%
Net Margin -14.85%
Return on Equity (ROE) -12.91%
Return on Assets (ROA) -7.94%
Asset Turnover 0.53x
Revenue 3-Yr CAGR 12.58%
🛡️

Financial Health & Liquidity

Current Ratio 4.26
Cash Ratio 1.81
Debt / Equity 0.409
Debt / Assets 0.251
Cash & Equivalents $159.62M
Total Debt $341.86M
Book Value / Share $6.42
💧

Cash Flow Efficiency

Operating Cash Flow $5.23M
Capital Expenditures (CapEx) $27.01M
Free Cash Flow -$21.78M
OCF / Revenue 0.72%
FCF / Revenue -2.99%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $6.42
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.36B
Total Liabilities $523.27M
Stockholders' Equity $836.56M
Current Assets $376.29M
Current Liabilities $88.30M